Comparison
Comparison close
Results

MEASURAND   SIR equivalent activity of Ac-225

 

Degrees of equivalence represented by Di = (xI - xR) and its expanded uncertainty Ui (k =2), both expressed in kBq.

Ac-225
Di / kBq
Participating institutes

Degrees of equivalence represented by Di = (xI - xR) and its expanded uncertainty Ui (k =2), both expressed in kBq/MBq.

Ac-225
Di / (kBq/MBq)
Participating institutes
Comparison
Comparison close
Results

MEASURAND   SIR equivalent activity of Ac-225

 

Degrees of equivalence represented by Di = (xI - xR) and its expanded uncertainty Ui (k =2), both expressed in kBq.

LABi Di Uneg,i Upos,i
kBq
kBq
kBq
PTB -280 560
POLATOM 280 560
Participating institutes
BIPM.RI(II)-K1.Ac-225

Degrees of equivalence represented by Di = (xI - xR) and its expanded uncertainty Ui (k =2), both expressed in kBq/MBq.

LABi Di Uneg,i Upos,i
kBq/MBq
kBq/MBq
kBq/MBq
PTB -3.7 7.5
POLATOM 3.8 7.5
Participating institutes
BIPM.RI(II)-K1.Ac-225
Comparison
Comparison close
BIPM comparison
Linked comparison
EURAMET.RI(II)-K2.Ac-225
Metrology area, Sub-field Ionizing Radiation, Section II (Measurement of Radionuclides)
Description Activity of radionuclide Ac-225
Time of measurements 2024 - 2025
Status Measurements in progress
Measurand Activity of 225Ac per unit mass
Transfer device Ampoules of Ac-225
Comparison type Key Comparison
Consultative Committee CCRI (Consultative Committee for Ionizing Radiation)
Conducted by EURAMET (European Association of National Metrology Institutes)
RMO Internal Identifier EURAMET Project No 1682
Comments Key Comparison of Ac-225 in the framework of the AlphaMet project:
Comparison of measurements standards of Ac-225 between seven radionuclide metrology institutes in the framework of the European project AlphaMet started in 2023 for a duration of three years. The aim of this project is to address metrological challenges of emerging alpha-emitting radiopharmaceuticals investigated in pre-clinic and clinic centres for Targeted Alpha Therapy. The goal is also to support the implementation of end-to-end traceability for alpha therapies before wide routine adoption.
Ra-225 as a salt shipped from CERN-MEDICIS. The chemical separation for the preparation of the ampoules with Ac-225 solution carried out at NPL. The shipment of ampoules to participants is performed by NPL.
Pilot institute LNE-LNHB
Commissariat à l'énergie atomique / Laboratoire National Henri Becquerel
France
Contact person Christophe BOBIN

+33 169082964
First Name Last Name
wwww@ww.www +356719836 Institute 1 Institute 1 Khmelnitskiy
Pilot laboratory
LNE-LNHB

Commissariat à l'énergie atomique / Laboratoire National Henri Becquerel, France, EURAMET

Comparison
Comparison close
Results

MEASURAND   SIR equivalent activity of Ac-225

 

The SIR reference value for this radionuclide is xR = 74 800 kBq, with a standard uncertainty uR = 280 kBq.
xR
is calculated by using the power-moderated weighted mean of the SIR results (see Section 4.1 of the Final Report).
The value xi is taken as the equivalent activity for a laboratory i.

 

The degree of equivalence of each laboratory with respect to the reference value is given by a pair of terms: Di = (x- xR) and Ui its expanded uncertainty (k = 2), both expressed in kBq, and Ui = 2((1 - 2wi)ui2 + u2R)1/2, where wi is the weight of laboratory i contributing to the calculation of xR.

The Degrees of equivalence are also given in relative terms by Di = (xI - xR) /xR and its expanded uncertainty Ui at a 95 % level of confidence, both expressed in kBq/MBq.

Comparison
Comparison close
Results

MEASURAND   SIR equivalent activity of Ac-225

 

xi   equivalent activity measured by the SIR for a laboratory i, Labi

ui   combined standard uncertainty of xi

  Labi xi ui Date of measurement
    kBq kBq  
  PTB 74520 200 2019-06-21
  POLATOM 75080 210 2021-07-06